Literature DB >> 15007358

Epidemiology of anaphylaxis among children and adolescents enrolled in a health maintenance organization.

Kari Bohlke1, Robert L Davis, Frank DeStefano, S Michael Marcy, M Miles Braun, Robert S Thompson.   

Abstract

BACKGROUND: There is little information about the incidence of anaphylaxis from all causes.
OBJECTIVE: The objects of this study were (1) to estimate the incidence of anaphylaxis; (2) to explore the range of diagnoses attributed to an anaphylactic episode; and (3) to describe the clinical features of anaphylaxis.
METHODS: The study population consisted of children and adolescents enrolled at a health maintenance organization. We identified potential episodes of anaphylaxis occurring between 1991 and 1997 from automated databases and reviewed the medical record to confirm the diagnosis. We reviewed all diagnoses specific for anaphylaxis (eg, ICD-9 995.0, anaphylactic shock) and sampled from among other related diagnoses (eg, ICD-9 995.3, allergy unspecified). Estimation of the incidence of provider-diagnosed anaphylaxis was based on cases confirmed from among the specific diagnosis codes. Description of the clinical features of anaphylaxis involved all confirmed cases regardless of diagnosis.
RESULTS: We identified 67 episodes of anaphylaxis among children with diagnosis codes specific for anaphylaxis (10.5 episodes per 100,000 person-years). There was no increase in incidence over time. Review of samples of diagnoses not specific for anaphylaxis yielded an additional 18 episodes. Among all identified episodes (n = 85), mucocutaneous and respiratory manifestations were the most common. Seventy-one percent of episodes were treated in the emergency department. Nine episodes (11%) resulted in hospitalization.
CONCLUSIONS: The incidence of anaphylaxis did not increase during these years. A majority of episodes were treated in the emergency department. Anaphylaxis in this population was frequently diagnosed as another related condition, and the basis and implications of diagnostic practices in this disorder warrant further exploration.

Entities:  

Mesh:

Year:  2004        PMID: 15007358     DOI: 10.1016/j.jaci.2003.11.033

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  54 in total

1.  Food-induced anaphylaxis.

Authors:  Antonella Cianferoni; Antonella Muraro
Journal:  Immunol Allergy Clin North Am       Date:  2011-11-21       Impact factor: 3.479

2.  Multiple epinephrine doses for stinging insect hypersensitivity reactions treated in the emergency department.

Authors:  Susan A Rudders; Aleena Banerji; Daniel P Katzman; Sunday Clark; Carlos A Camargo
Journal:  Ann Allergy Asthma Immunol       Date:  2010-07       Impact factor: 6.347

Review 3.  The Epidemiology of Anaphylaxis.

Authors:  Joyce E Yu; Robert Y Lin
Journal:  Clin Rev Allergy Immunol       Date:  2018-06       Impact factor: 8.667

Review 4.  H1-antihistamines for the treatment of anaphylaxis with and without shock.

Authors:  A Sheikh; V m ten Broek; S G A Brown; F E R Simons
Journal:  Cochrane Database Syst Rev       Date:  2007-01-24

5.  Case fatality and population mortality associated with anaphylaxis in the United States.

Authors:  Larry Ma; Theodore M Danoff; Larry Borish
Journal:  J Allergy Clin Immunol       Date:  2013-12-14       Impact factor: 10.793

Review 6.  Epidemiology and Burden of Food Allergy.

Authors:  Christopher M Warren; Jialing Jiang; Ruchi S Gupta
Journal:  Curr Allergy Asthma Rep       Date:  2020-02-14       Impact factor: 4.806

Review 7.  [Anaphylaxis in childhood and adolescence].

Authors:  H Ott; S Lehmann; G Wurpts; H-F Merk; A Viardot-Helmer; E Rietschel; J M Baron
Journal:  Hautarzt       Date:  2007-12       Impact factor: 0.751

8.  The etiology and incidence of anaphylaxis in Rochester, Minnesota: a report from the Rochester Epidemiology Project.

Authors:  Wyatt W Decker; Ronna L Campbell; Veena Manivannan; Anuradha Luke; Jennifer L St Sauver; Amy Weaver; M Fernanda Bellolio; Eric J Bergstralh; Latha G Stead; James T C Li
Journal:  J Allergy Clin Immunol       Date:  2008-11-06       Impact factor: 10.793

9.  Anaphylaxis in referred pediatric patients: demographic and clinical features, triggers, and therapeutic approach.

Authors:  Liliane F A De Swert; Dominique Bullens; Marc Raes; Anna-Maria Dermaux
Journal:  Eur J Pediatr       Date:  2008-01-17       Impact factor: 3.183

10.  Trends in national incidence, lifetime prevalence and adrenaline prescribing for anaphylaxis in England.

Authors:  Aziz Sheikh; Julia Hippisley-Cox; John Newton; Justin Fenty
Journal:  J R Soc Med       Date:  2008-03       Impact factor: 5.344

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.